Universal Biosensors Signs US Distribution Deal for Its Coagulation Monitoring Device
Universal Biosensors Flat Despite Fresh Deal With US Medical Product Distributor
Will Universal Biosensors (ASX:UBI) Spend Its Cash Wisely?
Universal Biosensors Inc: Q3 2024 Results
Universal Biosensors Wins AU$450,000 Deal in Italy
Universal Biosensors Inc: Half Year Results Presentation - 30 June 2024
Universal Biosensors Inc: Appendix 4D and Half Year Results - 30 June 2024
Universal Biosensors Raises AU$10 Million via Entitlement Offer
Universal Biosensors Narrows Q1 Loss as Revenue Rises; Shares Fall 3%
Universal Biosensors Opens AU$10 Million Rights Issue
Universal Biosensors to Raise AU$10 Million for Technology Development
H&G High Conviction Reports Flat Performance for March Quarter
Australian Shares Rise as Central Bank Maintains Interest Rates
Universal Biosensors Secures FDA Approval for Xprecia Prime, Paving Way for US Market Expansion
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%
This ASX Healthcare Stock Is up 72% on FDA News and 'Historic Moment'
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%
Universal Biosensors Grows H2 2023 Sales by 55%
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India
No Data
No Data